News

The outlook for Germany’s Bayer looks increasingly grim as court damages tied to the weedkiller Roundup begin to pile up. A jury in California on Monday awarded more than $2 billion to a couple ...
Bayer AG’s shares dropped after the German conglomerate was ordered by a jury in the US state of Georgia to pay almost $2.1 billion to a plaintiff who claimed its Roundup weedkiller caused ...
Bayer/Monsanto Hit Again With $2 Billion Verdict in Roundup Case by: Food and Drug Law at Keller and Heckman of Keller and Heckman LLP - The Daily Intake Thursday, May 16, 2019 ...
Bayer shares resumed their monthslong fall after the company was hit by a more-than $2 billion jury award over its Roundup herbicide, marking a sharp escalation in the chemical and drug giant’s ...
BERLIN (Reuters) -Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company’s Roundup weed killer caused his cancer, the plaintiff ...
Bayer’s stock fell nearly 2 percent Tuesday afternoon, a day after jurors awarded $2 billion to a California couple who blamed their cancer diagnoses on the company’s Roundup weed killer.
So far, Bayer has paid about $10 billion to settle claims that Roundup and glyphosate cause cancer. The company has set aside $5.9 billion more for ongoing litigation, according to its 2024 annual ...
NEW YORK, June 4 (Reuters) - A Pennsylvania judge on Tuesday slashed a $2.25 billion U.S. verdict against Bayer , opens new tab to $400 million for a Pennsylvania man who said he developed cancer ...
The outlook for Germany’s Bayer looks increasingly grim as court damages tied to the weedkiller Roundup begin to pile up. A jury in California on Monday awarded more than $2 billion to a couple ...
A jury in California on Monday awarded more than $2 billion to a couple who claimed that the product caused their cancer. Bayer, the inventor of aspirin, bought Roundup maker Monsanto just last year.